NCT06466356 Psychoeducational Course for Suicide Prevention
| NCT ID | NCT06466356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Olavs Hospital |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-06-03 |
| Primary Completion | 2031-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-06-03 with a primary completion date of 2031-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and detecting early warning signals for increased suicide risk. The course culminates in working on completing a individual safety plan to prevent an future increase in suicide risk. The course will incorporate both patients and their next of kin. The psychoeducational course will be compared to a control group where the patients receive one individual session with focus on a safety plan to evaluate the intervention. Both groups will receive treatment as usual (TAU) during both the acute phase and follow-up. The study will be conducted as a randomized controlled trial.
Eligibility Criteria
Inclusion Criteria: * Patients with a suicide attempt, suicidal behavior, or risk of suicidal behavior and a clinician evaluating that the patient has an intention to die * Patients with a suicide attempt or suicidal behavior defined as "a self-inflicted, potentially injurious behavior with a non-fatal outcome for which there is evidence of intention of death and/or considered to have had or been close to a suicidal crisis syndrome. Exclusion Criteria: * Not being sufficiently fluent in Norwegian to provide informed consent, valid responses on psychometric testing or to benefit from a psychoeducative course. * A known diagnosis of ICD-10 F 60.3 (borderline personality disorder) with similar symptoms at previous admittances. * Ongoing psychosis. * A substance abuse condition to such a degree that they are unable to comply with the protocol and are considered to be at risk when attending psychoeducational courses. * Organic brain disorders or mental disabilities in such a degree that they are unable to comply with the protocol. * Not being able to give an informed consent
Contact & Investigator
Katrine K Fjukstad, PhD
PRINCIPAL INVESTIGATOR
Helse Nord Trøndelag
Frequently Asked Questions
Who can join the NCT06466356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06466356 currently recruiting?
Yes, NCT06466356 is actively recruiting participants. Contact the research team at katrine.k.fjukstad@ntnu.no for enrollment information.
Where is the NCT06466356 trial being conducted?
This trial is being conducted at Levanger, Norway, Trondheim, Norway.
Who is sponsoring the NCT06466356 clinical trial?
NCT06466356 is sponsored by St. Olavs Hospital. The principal investigator is Katrine K Fjukstad, PhD at Helse Nord Trøndelag. The trial plans to enroll 80 participants.